CCOP, Hematology-Oncology Associates of CNY

Syracuse, New York 13057

0 studies enrolling now · 1 studies all time

What they study most

Invasive Breast Cancer

Studies at this site

• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed